Anne von Gottberg Selected Research

Tuberculosis (Tuberculoses)

1/2020	Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data.
1/2017	The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012-2014.
1/2016	The Epidemiology of Meningitis among Adults in a South African Province with a High HIV Prevalence, 2009-2012.
1/2016	Autopsy Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa.
10/2012	Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008.
3/2008	Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study.
11/2003	Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in a South African child in a tuberculosis treatment facility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne von Gottberg Research Topics

Disease

28	Pneumococcal Infections 01/2023 - 06/2004
19	Infections 11/2023 - 07/2007
15	COVID-19 03/2024 - 01/2020
12	Meningitis 01/2022 - 11/2008
7	Tuberculosis (Tuberculoses) 01/2020 - 11/2003
6	Reinfection 01/2023 - 01/2021
6	HIV Infections (HIV Infection) 01/2023 - 10/2012
6	Human Influenza (Influenza) 09/2021 - 04/2016
4	Coinfection 05/2024 - 01/2014
4	Bacterial Meningitis 08/2023 - 01/2019
4	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 10/2021 - 01/2019
4	Meningococcal Infections 01/2019 - 04/2011
2	Whooping Cough (Pertussis) 12/2023 - 01/2021
2	Sepsis (Septicemia) 01/2022 - 01/2016
2	Pneumonia (Pneumonitis) 01/2021 - 05/2009
2	Pneumococcal Pneumonia 01/2017 - 01/2014
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2015 - 01/2014
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 05/2009 - 03/2008
1	Bronchiolitis 11/2023
1	Asymptomatic Infections 12/2022
1	Breakthrough Infections 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2011
1	Opportunistic Infections (Opportunistic Infection) 01/2011

Drug/Important Bio-Agent (IBA)

27	VaccinesIBA 01/2024 - 11/2011
25	Conjugate VaccinesIBA 01/2023 - 06/2004
11	N-(2-cyanoethylene)urea (BA 1)IBA 05/2024 - 01/2022
7	N-methyl-valyl-amiclenomycin (BA 2)IBA 05/2024 - 01/2022
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2012
4	Oxygen (Dioxygen)IBA 10/2023 - 01/2014
3	COVID-19 VaccinesIBA 01/2024 - 08/2022
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2021
3	10-valent pneumococcal conjugate vaccineIBA 01/2023 - 01/2021
3	AntibodiesIBA 01/2023 - 12/2021
3	Bacterial VaccinesIBA 01/2021 - 01/2019
3	FluoroquinolonesIBA 05/2009 - 11/2003
2	Acellular VaccinesIBA 12/2023 - 01/2021
2	AntigensIBA 08/2022 - 01/2021
2	BNT162 VaccineIBA 01/2022 - 12/2021
2	Immunodominant EpitopesIBA 03/2021 - 01/2021
2	insulin receptor-related receptor (IRR)IBA 01/2021 - 04/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2014
2	Penicillins (Penicillin)FDA Link 11/2012 - 11/2008
2	Levofloxacin (Levaquin)FDA Link 05/2009 - 03/2008
1	RNA (Ribonucleic Acid)IBA 01/2024
1	phytobacteriomycin (PBM)IBA 08/2023
1	cyclo(Arg-Pro) (CI 4)IBA 01/2023
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2023
1	Streptococcus pneumoniae plY proteinIBA 01/2022
1	Viral RNAIBA 01/2022
1	Liposomes (Liposome)IBA 01/2022
1	Ad26COVS1IBA 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2021
1	ChemokinesIBA 10/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021
1	CytokinesIBA 10/2021
1	Amino Acids FDA Link 09/2021
1	Hemagglutinins (Hemagglutinin)IBA 09/2021
1	Polysaccharides (Glycans)IBA 01/2020
1	lipoarabinomannan (LAM)IBA 01/2020
1	Capsules (Microcapsules)IBA 01/2020
1	CI 22IBA 01/2017
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 06/2014
1	Interleukin-6 (Interleukin 6)IBA 05/2014
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 03/2012
1	Meningococcal Vaccines (Meningococcal Vaccine)IBA 04/2011
1	MacrolidesIBA 07/2008
1	aerobactinIBA 07/2007

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2014
2	Art Therapy 03/2024 - 01/2016
2	Artificial Respiration (Mechanical Ventilation) 01/2015 - 01/2015
1	Prenatal Care (Care, Prenatal) 12/2022
1	Treatment Delay 01/2020
1	Length of Stay 01/2017
1	Medical Day Care (Partial Hospitalization) 01/2015
1	Highly Active Antiretroviral Therapy (HAART) 01/2011